Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products. The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health profess...
Khiron Life Sciences reported revenue of $12.80 million for fiscal year 2021, up 59.6% from fiscal year 2020, and net income of -$33.13 million. In Q3 2022 (the quarter ended September 30, 2022) revenue was $3.39 million, down 3.8% from a year before.
Figures from company filings; latest fiscal year ended December 31, 2021.
No profile data available.